Subcutaneous Rheumatoid Nodules
Links shared publicly online about this topic
Subcutaneous Formulation of Orencia Approved for Rheumatoid Arthritis - MPR
empr.com — “The FDA has approved a subcutaneous formulation of Orencia (abatacept; Bristol-Myers Squibb) for the reduction of signs and symptoms in adults with moderate to severe rheumatoid arthritis (RA).” View full resource at empr.com
Most Recently Shared on August 1, 2011 at 2:49 pm By:
MPR News: Subcutaneous Formulation of Orencia Approved for Rheumatoid Arthritis: The FDA has approved a subcutan... http://bit.ly/njnX58
Subcutaneous Fat Necrosis of the Newborn: eMedicine Dermatology
emedicine.medscape.com — “Overview: Subcutaneous fat necrosis of the newborn (SCFN) is an uncommon disorder characterized by firm, erythematous nodules and plaques over the trunk, arms, buttocks, thighs, and cheeks of full-term newborns. The nodules and plaques appear in the ...” View full resource at emedicine.medscape.com
Most Recently Shared on April 19, 2010 at 6:42 pm By:
Julie Bohlen Health Executive and Active Health Library
A rare condition, subcutaneous fat necrosis of the newborn results in firm, inflammed lumps in fat weeks after birth.http://bit.ly/9JwgeH
Abatacept has received FDA approval as a Subcutaneous Injection for Rheumatoid Arthritis http://ow.ly/5TWbD
medpagetoday.com — “Abatacept has received FDA approval as a Subcutaneous Injection for Rheumatoid Arthritis http://ow.ly/5TWbD” View full resource at medpagetoday.com
Most Recently Shared on August 3, 2011 at 10:45 am By:
Dr Irwin Lim Rheumatologist, Physician, Active Health Library, and Doctor
Abatacept has received FDA approval as a Subcutaneous Injection for Rheumatoid Arthritis http://ow.ly/5TWbD
Juvenile Rheumatoid Arthritis and Diet
kidshealth.org — “Learn about juvenile rheumatoid arthritis, a specific kind of arthritis that usually occurs in kids and teens under age 17.” View full resource at kidshealth.org
Most Recently Shared on December 22, 2009 at 2:09 pm By:
Susan Scroggins Active Health Library and Health Advocate
Juvenile rheumatoid arthritis and nodules: Rheumatoid nodules are symptoms of the polyarticular type. Learn more: http://bit.ly/bDr0x9
U.S. Food and Drug Administration Approves Subcutaneous Formulation of Orencia (abatacept), a Proven Non-Anti-TNF Biologic for Adults with Moderate to Severe Rheumatoid Arthritis
drugs.com — “Orencia (abatacept) is used for the treatment of rheumatoid arthritis. Information from Drugs.com includes Orencia side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on August 2, 2011 at 12:27 am By:
FDA Approves Subcutaneous Formulation of Orencia - http://bit.ly/pjN8oc
U.S. Food and Drug Administration Approves Subcutaneous Formulation of Orencia (abatacept), a Proven Non-Anti-TNF Biologic for Adults with Moderate to Severe Rheumatoid Arthritis
drugs.com — “Orencia (abatacept) is used for the treatment of rheumatoid arthritis. Information from Drugs.com includes Orencia side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on August 2, 2011 at 12:14 am By:
Drugs and Devices OW OW Health
U.S. Food and Drug Administration Approves Subcutaneous Formulation of Orencia (abatacept), a Proven Non-A... http://bit.ly/qnjY9u #drug
New Data Show That Subcutaneous Injection Of An Investigational Formulation Of ORENCIA® Provided Similar Improvemnt Compared To Intraveous Therapy
medicalnewstoday.com — “(NYSE:BMY) announced that new Phase III clinical data show that a weekly subcutaneous injection of an investigational formulation of ORENCIA® (abatacept), following a single intravenous (I.V.)” View full resource at medicalnewstoday.com
Most Recently Shared on November 10, 2010 at 5:05 pm By:
MNT Arthritis News Health News
New Data Show That Subcutaneous Injection Of An Investigational Formulation Of ORENCIA® Provided Similar Improvemn... http://mnt.to/3Mm7
Rheumatology Article | Evaluation of abatacept administered subcutaneously in adults with active rheumatoid arthritis: impact of withdrawal and reintroduction on immunogenicity, efficacy and safety (phase Iiib ALLOW study)
mdlinx.com — “Evaluation of abatacept administered subcutaneously in adults with active rheumatoid arthritis: impact of withdrawal and reintroduction on immunogenicity, efficacy and safety (phase Iiib ALLOW study)” View full resource at mdlinx.com
Most Recently Shared on October 11, 2011 at 3:09 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Evaluation of abatacept administered subcutaneously in adults with active rheumatoid arthritis: im... http://t.co/AjrL6Osy #Rheumatology
SIMPONI" (Golimumab) Receives Positive Opinion from Chmp for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
jnj.com — “Johnson & Johnson news and information regarding our operations, products, leaders, and our charitable giving.” View full resource at jnj.com
Most Recently Shared on June 26, 2009 at 4:22 pm By:
eyeonfda Pharma and Health Lawyer
J&Js SIMPONIâ„¢ (Gets Thumbs Up from Chmp for 1xMonth Subcut Trtmnt of RA, Psoriatic Arthritis and Ankylosing Spondylitis http://bit.ly/5oiTM
UPDATE 1-Bristol-Myers gets FDA ok for subcutaneous Orencia | Reuters
reuters.com — “* Drug will be commercially available in the US in Sept. July 29 (Reuters) - Biopharmaceutical company Bristol-MyersSquibb Co said the U.S. Food and Drug Administrationapproved a subcutaneous” View full resource at reuters.com
Most Recently Shared on July 30, 2011 at 1:34 pm By:
Drugs and Devices OW OW Health
Bristol-Myers gets FDA ok for subcutaneous Orencia - Reuters: RTT NewsBristol-Myers gets FDA ok for subcut... http://bit.ly/qiLwaG #drug
U.S. Food And Drug Administration Accepts Supplemental Biologics License Application For Subcutaneous Formulation Of ORENCIA® (abatacept)
medicalnewstoday.com — “Bristol-Myers Squibb Company (NYSE: BMY) announced that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA) for the subcutaneous” View full resource at medicalnewstoday.com
Most Recently Shared on December 9, 2010 at 6:55 pm By:
MNT Arthritis News Health News
U.S. Food And Drug Administration Accepts Supplemental Biologics License Application For Subcutaneous Formulation Of O... http://mnt.to/3NPD
Biologics for Rheumatoid Arthritis: No Cure-all
webmd.com — “Biologic therapies often prescribed for rheumatoid arthritis do help improve symptoms but don't eliminate them, according to a new study.” View full resource at webmd.com
Most Recently Shared on May 4, 2009 at 3:30 pm By:
Biologics for Rheumatoid Arthritis: No Cure-all: Biologic therapies often prescribed for rheumatoid arthritis do.. http://tinyurl.com/cmsgk5
Symptoms of RA - Medbroadcast
medbroadcast.com — “RA causes swelling in the lining of the joints, which leads to redness, pain, swelling, and a feeling of heat or warmth in the area. Morning stiffness of the joints can last at least an hour. You may also feel fatigued or ill, have dry eyes or dry mouth, or have bumps under the skin called rheumatoid nodules.” View full resource at medbroadcast.com
Most Recently Shared on June 17, 2010 at 7:21 pm By:
Stomach bacteria may trigger rheumatoid arthritis: http://bit.ly/aLWwFI + symptoms of arthritis that can strike young: http://bit.ly/8ZXbHE
Rheumatology Medical News about Methotrexate Arthritis, Rheumatoid
mdlinx.com — “Are switches from oral to subcutaneous methotrexate or addition of ciclosporin to methotrexate useful steps in a tight control treatment strategy for rheumatoid arthritis? A post hoc analysis of the CAMERA study” View full resource at mdlinx.com
Most Recently Shared on June 15, 2010 at 2:30 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Are switches from oral to subcutaneous methotrexate or addition of ciclosporin to methotrexate useful... http://bit.ly/cET3nK #Rheumatology
New MRI Data Confirm Simponi (Golimumab) Efficacy in Treatment of Rheumatoid Arthritis - Drugs.com MedNews
drugs.com — “MONTREAL, Nov. 30 CNW - Magnetic resonance imaging (MRI) analyses from two Phase 3 clinical trials showed that once every four week subcutaneous injections of g” View full resource at drugs.com
Most Recently Shared on November 30, 2010 at 7:14 pm By:
Drugs and Devices OW OW Health
New MRI Data Confirm Simponi (Golimumab) Efficacy in Treatment of Rheumatoid Arthritis: MONTREAL, Nov. 30 ... http://bit.ly/ek7xoa #drug
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
-
Julie Bohlen
Health content professional with MBA in heathcare management. Sharing quality health resources and news. On executive team at OrganizedWisdom.
-
Dr Irwin Lim
Irwin obtained his fellowship with the Royal Australasian College of Physicians in 2003 in the specialty of Rheumatology. He enjoys treating all aspects of rheumatic disease. Irwin’s specific interests include osteoporosis, osteoarthritis and inflammatory arthritis.
As director of BJC Health, Irwin developed the initial clinic in Parramatta, Sydney to a multisite and multidisciplinary group. He strives to develop innovative, effective treatment solutions for patients suffering from chronic disease.
Irwin manages the clinic’s bone densitometry service. In 2009, he incorporated musculoskeletal ultrasound as a routine part of his clinical assessments. Already heavily involved in the clinic’s educational activities for allied health professionals and GPs, Irwin is now exploring the use of social media in patient education, and is the clinic’s principal blogger.
Advertisement
